Therefore, although IL-4 exhibits positive regulatory effects to boost insulin efficacy, the energy deposit-promoting activity of IL-4 may make the liver more susceptible to develop steatosis under insulin resistant and diabetic models. This evidence concerns the gene INS and steatosis.